Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Early Translation Branch (ETB)

Novel Coronavirus SARS-CoV-2
OpenData Portal: Sharing Data to Advance COVID-19 Research

NCATS created a new resource for scientists, the OpenData Portal, to openly and quickly share COVID-19-related drug repurposing data and experiments for all approved drugs.

A small protein sitting inside an immune cell docking station causes it to change shape.
Reprogramming Immune Cells to Fight Tumors

Immunotherapy holds immense power in harnessing the body’s immune system to fight diseases. Researchers have shown a novel type of immune therapy can reprogram immune cells to stop tumor growth and kill cancer cells.

About ETB

Find out more about how ETB experts help discover novel small molecule therapies across the spectrum of human diseases.

Scientific Capabilities

Access a collaborative team of experts in assay development, high-throughput screening, medicinal chemistry, informatics and drug development.

Work with ETB

Learn how to collaborate with ETB staff to pursue a drug target or screen of interest.

About ETB

Find out more about how ETB experts help discover novel small molecule therapies across the spectrum of human diseases.

Scientific Capabilities

Access a collaborative team of experts in assay development, high-throughput screening, medicinal chemistry, informatics and drug development.

Work with ETB

Learn how to collaborate with ETB staff to pursue a drug target or screen of interest.

Work with Us

ETB is highly collaborative and always encourages new partnership opportunities, including projects with NIH and external researchers as well as disease foundations and biotechnology companies. Learn more about how to work with us.

Looking for a chemical probe?

ETB experts have developed many small molecule probes for further therapeutic development.